- Forums
- ASX - By Stock
- ACW
- Ann: ACW XanaCIDD phase 2a trial topline results
Ann: ACW XanaCIDD phase 2a trial topline results, page-35
-
- There are more pages in this discussion • 81 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ACW (ASX) to my watchlist
|
|||||
Last
2.7¢ |
Change
-0.004(12.9%) |
Mkt cap ! $73.21M |
Open | High | Low | Value | Volume |
3.0¢ | 3.1¢ | 2.7¢ | $938.0K | 33.18M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
16 | 2741829 | 2.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.8¢ | 643372 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
16 | 2741829 | 0.027 |
10 | 1394588 | 0.026 |
24 | 4563643 | 0.025 |
10 | 2745804 | 0.024 |
3 | 154000 | 0.023 |
Price($) | Vol. | No. |
---|---|---|
0.028 | 643372 | 2 |
0.029 | 3351339 | 11 |
0.030 | 3008038 | 15 |
0.031 | 2250835 | 6 |
0.032 | 1078289 | 5 |
Last trade - 16.10pm 13/08/2024 (20 minute delay) ? |
Featured News
ACW (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online